Page 24 - Sun Pharma

Sun Pharma Q1 net zooms over 3-fold to Rs 2,034 crore

Company's consolidated total income from operations rose to Rs 8,242.99 crore for the first quarter of the current fiscal

Sun Pharma to launch diabetes tablet in US

Tablets may have an annual sales of around $1.2 billion in the country

Sun Pharma, Almirall enter pact for psoriasis novel biologic

Sun Pharma to receive $50 mn initially, apart from development & regulatory milestone payments, royalties on net sales

Sun Pharmaceutical gains on pact with Almirall for Psoriasis drug

Under terms of the license agreement, Almirall will pay Sun Pharma an initial upfront payment of US $50 million,

Sun Pharma in $50 million deal with Spanish firm Almirall

According to Sun Pharma, Almirall will be able to lead European studies, and participate in larger Global clinical studies for psoriasis indication subject to the terms of the Sun Pharma - Merck agreements

Sun, Glenmark, Aurobindo get USFDA nod for cholesterol drug Crestor

Crestor tablets had posted annual sales of around $6.78 billion in the 12 months ended May 2016

SPARC and Sun Pharma ink licensing pact for epilepsy drug

Shares of SPARC were trading 5.11% at Rs 367.50 apiece on BSE

Sun Pharma Advanced surges on licensing pact with Sun Pharma

SPARC was surged 7% to Rs 375, while Sun Pharma was up 1% at Rs 779 on the BSE.

Sun Pharma introduces anti-cancer product in Europe

Over the next few months, Sun Pharma will launch Gemcitabine InfuSMART across the Netherlands, the UK, Spain, Germany, Italy and France

Sun Pharma trades firm after board approves buyback of shares

The stock was trading flat at Rs 754 on the BSE, as compared to 3.5% fall in the S&P BSE Sensex.

Sun announces share buyback

On a year-on-year basis, Sun Pharma's stock is down 13.7%

Sun Pharma buyback offer a no-show

Given the offer size, it is hardly a blip on the screen

Sun Pharma bets on new products to boost US skincare products growth

Company has high hopes for tildrakizumab, an experimental psoriasis drug that recently completed late-stage trials

Sun Pharma gains ahead of board meet to mull share buyback proposal

The stock was up 2% at Rs 757 on the BSE.

2,839 bottles made by Sun Pharma Inc being recalled in US

The recall is due to failed dissolution specifications

Madras HC orders in favour of Sun Pharma in trademark dispute

The Court issued a permanent injunction against Cadila Healthcare using marks similar to Sun Pharma's particular trademark

Sun Pharma relaunches sunscreen brand to grow OTC business

Suncros will now be sold through both prescription and OTC mode

Sun Pharma launches sunscreen brand Suncros

Company has also signed former Miss India and actress Dia Mirza as Suncros' brand ambassador

Continue to remain opportunistic for acquisitions: Sun Pharma

Shanghvi said process of integrating Ranbaxy with Sun Pharma has commenced with a view to ensure business momentum and drive value creation

Sun Pharma sells two manufacturing plants in US to Frontida BioPharm

Sale part of drug maker's plans to consolidate its manufacturing facilities in US